It is crucial to select drugs for the prevention of fracture in postmenopausal osteoporosis. In early postmenopausal women with climacteric symptoms hormone replacement therapy (HRT) would be a first choice. Selective estrogen receptor modulator (SERM) could be prescribed in postmenopausal women who had been treated with HRT. Osteoporotic women with high risk of future fractures would be administered bisphosphonates. It is highly recommended that the doctor's decision on the drug (s) for each patient with osteoporosis could be made after obtaining the informed consent.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
drugs prevention
8
postmenopausal women
8
[absolute risk
4
risk fracture
4
fracture guideline
4
guideline selection
4
selection drugs
4
prevention fractures
4
postmenopausal
4
fractures postmenopausal
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!